Premium
Rotigotine: first dopamine agonist transdermal patch
Author(s) -
Metta Vinod,
Muzerengi Sharon,
Chaudhuri K Ray
Publication year - 2007
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.27
Subject(s) - rotigotine , medicine , transdermal patch , dopamine agonist , tolerability , transdermal , dopamine , agonist , pramipexole , pharmacology , anesthesia , parkinson's disease , dopaminergic , disease , adverse effect , receptor
Rotigotine (Neupro) is the first dopamine agonist skin patch to become available. Our New products review considers the clinical‐trial evidence for its efficacy and tolerability in the treatment of early and advanced Parkinson's disease. Copyright © 2007 Wiley Interface Ltd